Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Starling Registry Study

NCT04648293 is registered in ClinicalTrials.gov with Baxter Healthcare Corporation as lead sponsor.

NCT NCT04648293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04648293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Starling Registry Study
Lead sponsor
Baxter Healthcare Corporation
Phase
Observational
Overall status
Completed
Start date
November 16, 2020
Completion date
February 21, 2024
Enrollment
1,207 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hemodynamic monitoring